Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AnsellASX:ANN -0.75%76 EV-to-OCF is 12.69 as of Jul. 19, 2026, which is 11% below its 10-year median of 14.29. GuruFocus rates ASX:ANN with a GF Score™ of 76/100 and a GF Value™ of A$29.45 (Fairly Valued). The stock has 4 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Ansell ranks worse than 61.78% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Ansell's Enterprise Value is A$5,349 Mil.
Ansell's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was A$421 Mil. Therefore, Ansell's EV-to-OCF for today is 12.69.
The historical rank and industry rank for Ansell's EV-to-OCF or its related term are showing as below:
ASX:ANN'
s EV-to-OCF Range Over the Past 10 Years
Min: 7.95 Med: 14.29 Max: 25.63
Current: 12.69
During the past 13 years, the highest EV-to-OCF of Ansell was 25.63. The lowest was 7.95. And the median was 14.29.
ASX:ANN's EV-to-OCF is ranked worse than 61.78% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 7.76
vs ASX:ANN: 12.69
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-07-19), Ansell's stock price is A$31.67.
Ansell's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$1.409. Therefore, Ansell's PE Ratio (TTM) for today is 22.48.
Ansell (ASX:ANN) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Ansell's share price for today is A$31.67.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ansell's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$1.409.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Ansell EV-to-OCF Related Terms
Ansell EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Ansell's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Ansell's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ansell EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ansell's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Ansell's EV-to-OCF falls into.
Ansell's current Enterprise Value is A$5,349 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ansell's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was A$421 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ansell (ASX:ANN) has a EV-to-OCF of 12.69 as of Jul. 19, 2026. This is 11% below median its historical median of 14.29. Over the past decade, Ansell's EV-to-OCF has ranged from 7.95 to 25.63. According to the industry distribution chart, Ansell ranks #527 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 61.8%.
Is Ansell's EV-to-OCF too high?
Ansell's current EV-to-OCF of 12.69 is 11% below median its 10-year median of 14.29. Over the past 10 years, this metric has ranged from a low of 7.95 to a high of 25.63. The Medical Devices & Instruments industry median EV-to-OCF is 7.76. Ansell's value of 12.69 is 63.5% above this industry median. Based on the distribution chart, Ansell ranks #527 out of 853 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Ansell has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ansell's EV-to-OCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Ansell ranks #527 out of 853 companies for EV-to-OCF. This places Ansell in the lower half of its industry. The industry median EV-to-OCF is 7.76. Ansell's value of 12.69 is 63.5% above this benchmark. Historically, Ansell's own EV-to-OCF has ranged from 7.95 to 25.63 over the past decade. While the company's 10-year median is 14.29 vs. the industry median of 7.76, Ansell has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.76, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ansell's current EV-to-OCF of 12.69 is 63.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ansell's current EV-to-OCF is 12.69, which is 11% below median its own 10-year median of 14.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ansell stock overvalued right now?
Based on GuruFocus' analysis, Ansell (ASX:ANN) is currently considered Fairly Valued. The stock's GF Value™ is A$29.45, compared to a current price of A$31.67 — trading 7.5% above its estimated fair value. The current EV-to-OCF is 12.69, which is 11% below median its 10-year median of 14.29 and 63.5% above the Medical Devices & Instruments industry median of 7.76. Ansell's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Ansell (ASX:ANN), the current EV-to-OCF is 12.69 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ansell (ASX:ANN) Overvalued in 2026?
Based on GuruFocus' analysis, Ansell stock appears to be overvalued.
The current stock price of A$31.67 is trading 7.5% above its estimated GF Value™ of A$29.45.
GuruFocus considers Ansell to be Fairly Valued.
Key valuation signals for ASX:ANN:
EV-to-OCF: 12.69 (11% below median its 10-year median of 14.29)
GF Value™: A$29.45 vs. price of A$31.67 (7.5% above fair value)
Industry Position: 63.5% above the Medical Devices & Instruments median (#527 of 853)
No single metric tells the full story. See the ASX:ANN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 55% of revenue and operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents, and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly. Largest sales regions are North America and Europe, Middle East, and Africa. Asia-Pacific and Latin America, combined, are about one-fourth of sales.
76GF Score
Get the complete analysis for ASX:ANN
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ANN has been successfully added to your 
